Case 59: Immune Checkpoint Inhibitor - Nivolumab - Lung Injury / ILD and Recognizing Pre-Existing ILA/ILD
Immune checkpoint inhibitor lung injury is not uncommon and needs to be recognized
This 73-years old man presented with nivolumab induced lung injury with an organizing pneumonia (OP) pattern. He also had pre-existing interstitial lung abnormality (ILA).
The video discusses the case, the follow-up, immune checkpoint inhibitor (ICI) related lung injury, which is a growing problem and the importance of pre-existing ILA
This post is for paying subscribers only
SubscribeAlready have an account? Log in
